Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis
- PMID: 3857947
- DOI: 10.1002/bjs.1800720514
Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis
Abstract
A review of 90 patients presenting in Leeds over the period 1976-80 with synchronous hepatic metastases from colorectal cancer has been undertaken. The median survival for the group was 10.3 months (range 1-48 months). A multivariate analysis identified factors in the history and examination of the patient, results of biochemical and haematological investigations and characteristics of both the primary and secondary tumour, which influenced survival. Recognition of these factors allowed both a clinical scoring index and computer survival model to be constructed. When applied to the group as a whole both were reasonably accurate at predicting survival (62 per cent for the survival model and 66 per cent for the scoring index). However, the computer model correctly identified 80 per cent of the 'long-term' survivors (greater than 12 months from the time of diagnosis). It is concluded that many trials of therapy for hepatic metastases from colorectal cancer have failed to consider the natural history of the disease and the identification of prognostic indices should allow for adequate stratification within the treatment arms of any future study.
Similar articles
-
Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum.Dis Colon Rectum. 1982 Nov-Dec;25(8):749-54. doi: 10.1007/BF02553304. Dis Colon Rectum. 1982. PMID: 7172942
-
[Natural history of synchronous hepatic metastases from a non-treated colorectal cancer].J Chir (Paris). 1988 Jun-Jul;125(6-7):419-23. J Chir (Paris). 1988. PMID: 3209636 French.
-
[Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases].Ai Zheng. 2006 Sep;25(9):1153-7. Ai Zheng. 2006. PMID: 16965661 Chinese.
-
Colorectal cancer: the natural history of disseminated disease - a review.Aust N Z J Surg. 1980 Dec;50(6):643-6. doi: 10.1111/j.1445-2197.1980.tb04217.x. Aust N Z J Surg. 1980. PMID: 7008761 Review.
-
Surgical treatment of liver metastases in patients with colorectal cancer.Cancer. 1993 Jun 15;71(12 Suppl):4252-66. doi: 10.1002/1097-0142(19930615)71:12+<4252::aid-cncr2820711815>3.0.co;2-6. Cancer. 1993. PMID: 8508388 Review.
Cited by
-
Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma.Ann Surg. 1992 Oct;216(4):493-504; discussion 504-5. doi: 10.1097/00000658-199210000-00012. Ann Surg. 1992. PMID: 1417198 Free PMC article.
-
Resection of liver metastases from a colorectal carcinoma does not benefit the patient.Ann R Coll Surg Engl. 1990 May;72(3):199-205. Ann R Coll Surg Engl. 1990. PMID: 2192677 Free PMC article. Review.
-
Treatment for liver metastases from breast cancer: results and prognostic factors.World J Gastroenterol. 2005 Jun 28;11(24):3782-7. doi: 10.3748/wjg.v11.i24.3782. World J Gastroenterol. 2005. PMID: 15968739 Free PMC article.
-
Natural history of liver metastases from colorectal carcinoma.J Gastrointest Surg. 1997 Sep-Oct;1(5):398-407. doi: 10.1016/s1091-255x(97)80126-6. J Gastrointest Surg. 1997. PMID: 17061331 Review. No abstract available.
-
Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies.Br J Cancer. 2006 Apr 10;94(7):982-99. doi: 10.1038/sj.bjc.6603033. Br J Cancer. 2006. PMID: 16538219 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical